已收盘 07-02 16:00:00 美东时间
+0.450
+5.33%
火爆!24家大行集体上调派拓网络目标价,最高370美元;大摩上调美光目标价从520美元升至1050美元;犹他美容(ULTA)惨遭12家大行下调目标价>>
06-04 11:36
Majority of patients met the American College of Rheumatology improvement criteria (ACR70) response by Week 36Single-dose of miv-cel delivered deep B-cell depletion with evidence of immune resetMiv-cel continues to
06-03 20:09
今日重点评级关注:Chardan Capital:维持Senti Biosciences"买入"评级,目标价从11美元升至12美元;Ladenburg Thalmann:维持Usio"买入"评级,目标价从5.75美元升至6.25美元
05-18 11:48
今日重点评级关注:瑞杰金融:上调InflaRx评级至"强烈买入",目标价从7美元升至9美元;巴克莱:维持Orchestra BioMed Hldgs"超配"评级,目标价从12美元升至13美元
05-14 14:32
JP Morgan analyst Brian Cheng maintains Kyverna Therapeutics (NASDAQ:KYTX) with a Overweight and lowers the price target from $30 to $29.
05-13 23:33
Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(0.66) per share which beat the analyst consensus estimate of $(0.73) by 9.59 percent. This is a 35.92 percent increase over losses of $(1.03) per share
05-13 04:40
今日重点评级关注:花旗:维持Pegasystems"买入"评级,目标价从70美元升至71美元;巴克莱:维持曼哈顿联合软件"超配"评级,目标价从236美元升至239美元
04-24 12:10
FST Corp.涨47.54%;Kyverna Therapeutics, Inc.涨35.84%;Aspire Biopharma Holdings, Inc.涨18.85%
04-22 15:01
FST Corp.涨54.92%;Kyverna Therapeutics, Inc.涨42.43%;Aspire Biopharma Holdings, Inc.涨17.63%
04-22 13:01
FST Corp.涨58.20%;Kyverna Therapeutics, Inc.涨28.32%;Epsium Enterprise涨16.55%
04-22 10:01